Registered entities
Lantern Pharma, Inc.
Reg. No. 7801204United States
Lantern Pharma Inc.
Reg. No. 32052429233United States
Lantern Pharma Inc.
Reg. No. 1763950United States
Innovation
32 patent families (3 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace accelerating. Cited 309 times.
| Year | Filings |
|---|---|
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 12 |
| 2023 | 16 |
| 2024 | 17 |
| 2025 | 17 |
| 2026 | 13 |
Social engagement
Social engagement: 6.6K social following, 10 posts in the last 12 months — around the industry typical range.
Investor mix
5 investors on record; lead investors include Bios Partners, Green Park & Golf Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 40% |
| Angel & family office | 1 | 20% |
| Accelerator & incubator | 1 | 20% |
| Other / undisclosed | 1 | 20% |
Hiring activity
Hires occasionally
2 roles tracked across 1 of the last 12 months
29 May 2026 · Clinical Trial Manager · Plano, TX
13 May 2026 · Frontend Engineer — AI Drug Discovery Platform, Biopharma Software Engineer, AI Drug Discovery Scientist, Comp
1 Aug 2023 · R SHINY DEVELOPER (Remote position) (Remote)
Based on job postings tracked across public sources.
Recent activity
22 Jun 2026
Event
BIO 2026 Executive Roundtable
17 Jun 2026
Event
From Investor to CEO: A View on Life Sciences Today and Tomorrow
21 May 2026
Product launch
LP-300 in NSCLC